Role of the MRP1/ABCC1 Multidrug Transporter Protein in Cancer

No abstract is available for this paper.

• Publication year

  2007

• Venue

  IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/15216540701736285PMID 18085475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage.

  2007cited by this paper
• Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir

  2007cited by this paper
• Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease.

  2006cited by this paper
• Effects of LPS stimulation on the expression of prostaglandin carriers in the cells of the blood‐brain and blood‐cerebrospinal fluid barriers

  2006cited by this paper
• Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)

  2006cited by this paper
• Transport of glutathione and glutathione conjugates by MRP1.

  2006cited by this paper
• Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.

  2006influential reference
• Topotecan is a substrate for multidrug resistance associated protein 4.

  2006cited by this paper
• Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.

  2006cited by this paper
• Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1)

  2006cited by this paper
• The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1

  2006cited by this paper
• The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).

  2006cited by this paper
• Targeting multidrug resistance in cancer

  2006cited by this paper
• Prostanoid transport by multidrug resistance protein 4 (MRP4/ABCC4) localized in tissues of the human urogenital tract.

  2005cited by this paper
• The role of the multidrug resistance-associated protein 1 gene in neuroblastoma biology and clinical outcome.

  2005influential reference
• Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro

  2005cited by this paper
• Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

  2005cited by this paper
• MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma

  2004cited by this paper
• MYCN in neuronal tumours.

  2004cited by this paper
• Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).

  2003cited by this paper
• Effect of the multidrug resistance protein on the transport of the antiandrogen flutamide.

  2003cited by this paper
• To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.

  2003cited by this paper
• Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy

  2003cited by this paper
• Characterization of the MRP4- and MRP5-mediated Transport of Cyclic Nucleotides from Intact Cells*

  2003cited by this paper
• Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma.

  2003cited by this paper
• Neuroblastoma: biological insights into a clinical enigma

  2003cited by this paper
• Relationship Between Chemotherapy Response of Small Cell Lung Cancer and P-glycoprotein or Multidrug Resistance-Related Protein Expression

  2002cited by this paper
• In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: A potential role in neuroblastoma therapy

  2002cited by this paper
• P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients.

  2001cited by this paper
• MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells

  2001cited by this paper
• MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines

  2000cited by this paper
• Structural, mechanistic and clinical aspects of MRP1.

  1999cited by this paper
• Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells

  1999cited by this paper
• Expression analysis of multidrug resistance associated genes in neuroblastomas.

  1999cited by this paper
• Multidrug resistance-associated protein and mutant p53 protein expression in non-small cell lung cancer.

  1998cited by this paper
• The expression of drug resistance gene products during the progression of human prostate cancer.

  1998cited by this paper
• Targeted expression of MYCN causes neuroblastoma in transgenic mice

  1997cited by this paper
• The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.

  1997cited by this paper
• Multidrug resistance protein in recurrent breast cancer.

  1997cited by this paper
• Absence of the canalicular isoform of the MRP gene–encoded conjugate export pump from the hepatocytes in Dubin‐Johnson syndrome

  1996cited by this paper
• Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.

  1996cited by this paper
• Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer.

  1995cited by this paper
• Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.

  1994cited by this paper
• Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture

  1985cited by this paper
• Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma

  1985cited by this paper
• Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

  1985cited by this paper
• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

  1976cited by this paper

• Differential Expression Patterns of SLCO Solute Carriers in Human Breast Cancer Cell Lines and Tumour Samples

  2025cites this paper
• A comprehensive review on the role of nitrogen containing heterocycles in overcoming ABC transporter mediated multidrug resistance in cancer.

  2025cites this paper
• Tetrahydroquinoline/4,5-dihydroisoxazoline hybrids counteracts multidrug resistance by inhibiting MRP1-mediated drug efflux.

  2025cites this paper
• LA-ICP-TOFMS Imaging Reveals Significant Influence of Cancer Cell Resistance on Oxaliplatin Compartmentalization in the Tumor Microenvironment

  2025cites this paper
• Comparative Analysis of Chemotherapy Resistance Mechanisms in Humans and Companion Animals

  2025cites this paper
• ABCC1 promotes GSH-dependent iron transport and resistance to Fe(II) and Cu(II) chelators

  2025cites this paper
• The role and therapeutic potential of glucose metabolism in multidrug resistance of cancer

  2025cites this paper
• The Level of a Short Form of Multidrug Resistance‐Associated Protein 1 Is Elevated in Plasma Small Extracellular Vesicles Derived From Patients With Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• Synergistic Solutions: Exploring Clotrimazole’s Potential in Prostate and Bladder Cancer Cell Lines

  2024cites this paper
• Unsymmetrical Bisacridines’ Interactions with ABC Transporters and Their Cellular Impact on Colon LS 174T and Prostate DU 145 Cancer Cells

  2024cites this paper
• Vitamin B12 Metabolism: A Network of Multi-Protein Mediated Processes

  2024cites this paper
• Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide

  2024cites this paper
• Targeted Cancer Stem Cell Therapeutics: An Update.

  2024cites this paper
• Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: A systematic review.

  2024cites this paper
• TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer

  2024cites this paper
• Chitosan and hyaluronic acid in colorectal cancer therapy: A review on EMT regulation, metastasis, and overcoming drug resistance.

  2024cites this paper
• The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents.

  2023cites this paper
• Nucleic acid drug vectors for diagnosis and treatment of brain diseases

  2023cites this paper
• The Sojourn of Polymeric Micelles for Effective Brain Drug Delivery System.

  2023cites this paper
• Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery.

  2023cites this paper
• Forkhead box proteins as the critical regulators of cisplatin response in tumor cells.

  2023cites this paper
• The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy

  2023influential citation
• Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR

  2023cites this paper
• Potential suppression of multidrug-resistance-associated protein 1 by coumarin derivatives: an insight from molecular docking and MD simulation studies

  2023cites this paper
• Macrophages enhance cisplatin resistance in gastric cancer through the transfer of circTEX2

  2023cites this paper
• Challenges and advances for glioma therapy based on inorganic nanoparticles

  2023cites this paper
• MicroRNA-185: a non-invasive diagnostic and prognostic tumor marker

  2023cites this paper
• Landscape of NcRNAs involved in drug resistance of breast cancer

  2023cites this paper
• Inhibition of CD73 expression or A2AR blockade reduces MRP1 expression and increases the sensitivity of cervical cancer cells to cisplatin

  2023cites this paper
• Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat.

  2023cites this paper
• A Novel NCI-H69AR Drug-Resistant Small-Cell Lung Cancer Mini-Tumor Model for Anti-Cancer Treatment Screening

  2023cites this paper
• The potential applications of microparticles in the diagnosis, treatment, and prognosis of lung cancer

  2022cites this paper
• Applications of Nanotechnology-Based Approaches to Overcome Multi-Drug Resistance in Cancer.

  2022cites this paper
• The history of small extracellular vesicles and their implication in cancer drug resistance

  2022cites this paper
• Dissection of the Role of Multidrug Resistance Protein in Cancer

  2022cites this paper
• A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses

  2022cites this paper
• Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects

  2022cites this paper
• Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance

  2022cites this paper
• A critical review on modulators of Multidrug Resistance Protein 1 in cancer cells

  2022cites this paper
• Magnetoelectric core–shell CoFe2O4@BaTiO3 nanorods: their role in drug delivery and effect on multidrug resistance pump activity in vitro

  2022cites this paper
• Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery

  2022cites this paper
• Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer

  2022cites this paper
• ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates

  2021cites this paper
• Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells

  2021cites this paper
• The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells

  2021cites this paper
• MicroRNA-Responsive DNA-Programmed Nanomedicine with Controllability of Cascaded Events for Cancer Therapy Enhancement.

  2021cites this paper
• Extracellular mutation induces an allosteric effect across the membrane and hampers the activity of MRP1 (ABCC1)

  2021cites this paper
• Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy

  2021cites this paper
• Enhanced expression of cyclooxygenase‐2 related multi‐drug resistance gene in melanoma and osteosarcoma cell lines by TSG‐6 secreted from canine adipose‐derived mesenchymal stem/stromal cells

  2021cites this paper
• Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway

  2021cites this paper
• A multidrug resistance‐associated protein inhibitor is a potential enhancer of the benzyl isothiocyanate‐induced apoptosis induction in human colorectal cancer cells

  2021cites this paper
• Microfluidic studies of hydrostatic pressure-enhanced doxorubicin resistance in human breast cancer cells.

  2021cites this paper
• Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers

  2021cites this paper
• University of and the creation of a tumour-conducive microenvironment in neuroblastoma

  2021cites this paper
• Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter.

  2021cites this paper
• Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis

  2021cites this paper
• Inhibitory Effects of Salinispora-derived Metabolites Against Multidrug Resistance: An In-silico Study

  2021cites this paper
• RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1)

  2021cites this paper
• Advantages and disadvantages of disulfiram coadministered with popular addictive substances.

  2021cites this paper
• Targeting Drug Chemo-Resistance in Cancer Using Natural Products

  2021cites this paper
• Role of glutathione in ferroptosis of tumor cells

  2021cites this paper
• Identification of Protein Markers Predictive of Drug-Specific Survival Outcome in Cancers

  2021cites this paper
• The Keap1-Nrf2 Signaling Pathway in Lung Cancer

  2021cites this paper
• Application of CRISPR/Cas9 System to Reverse ABC-Mediated Multidrug Resistance.

  2021cites this paper
• Breaking the Silence of Tumor Response: Future Prospects of Targeted Radionuclide Therapy.

  2021cites this paper
• CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer

  2021cites this paper
• SLCO and SLC22 Solute Carriers: Establishing Differential Expression Patterns in Human Breast Cancer Cell Lines and Tumour Samples

  2021cites this paper
• Targeting epithelial-mesenchymal transition - an ongoing wild goose chase

  2020cites this paper
• Aberrant DNA Methylation of ABC Transporters in Cancer

  2020cites this paper
• Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines

  2020cites this paper
• Rab21, an Endocytic Rab GTPase, is Involved in Drug Resistance in Prostate Cancer Cells

  2020cites this paper
• Theoretical Insights into the Cotransport Mechanism of GSH with Anticancer Drugs by MRP1.

  2020cites this paper
• Overcoming efflux transporter-mediated resistance in cancer by using nanomedicines

  2020cites this paper
• Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment.

  2020cites this paper
• Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).

  2020cites this paper
• The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer

  2020cites this paper
• Self-Propelling Targeted Magneto-Nanobots for Deep Tumor Penetration and pH-Responsive Intracellular Drug Delivery

  2020cites this paper
• The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells

  2020influential citation
• Potential targets for tumor-specific imaging of vulvar squamous cell carcinoma: A systematic review of candidate biomarkers.

  2020cites this paper
• Forkhead promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma.

  2020cites this paper
• Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance

  2020cites this paper
• Testing equality of means in partially paired data with incompleteness in single response

  2019cites this paper
• Chemo-sensitizing activity of natural cadinanes from Heterotheca inuloides in human uterine sarcoma cells and their in silico interaction with ABC transporters.

  2019cites this paper
• Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization

  2019cites this paper
• Asymptotic‐based bootstrap approach for matched pairs with missingness in a single arm

  2019cites this paper
• Supervised Discriminative Sparse PCA for Com-Characteristic Gene Selection and Tumor Classification on Multiview Biological Data

  2019cites this paper
• Expression pattern of estrogen receptor β and its correlation with multidrug resistance in non-small cell lung cancer.

  2019cites this paper
• From “Junk DNA” to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAs

  2019cites this paper
• miR-7 Reverses Breast Cancer Resistance To Chemotherapy By Targeting MRP1 And BCL2

  2019cites this paper
• miR-7 Reverses Breast Cancer Resistance To Chemotherapy By Targeting MRP1 And BCL2

  2019cites this paper
• Cell proliferation and invasion are regulated differently by EGFR and MRP1 in T-DM1-resistant breast cancer cells

  2019cites this paper
• Role of Four ABC Transporter Genes in Pharmacogenetic Susceptibility to Breast Cancer in Jordanian Patients

  2019cites this paper
• miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway

  2019cites this paper
• Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy

  2019cites this paper
• Diltiazem potentiation of doxorubicin cytotoxicity and cellular uptake in human breast cancer cells

  2019cites this paper
• Drug resistance and combating drug resistance in cancer

  2019cites this paper
• Endogenous Stimuli-Responsive Nucleus-Targeted Nanocarrier for Intracellular mRNA Imaging and Drug Delivery.

  2018cites this paper
• Different morphological structures of breast tumors demonstrate individual drug resistance gene expression profiles.

  2018cites this paper
• Clinical relevance of the multidrug resistance‑associated protein 1 gene in non‑small cell lung cancer: A systematic review and meta‑analysis.

  2018cites this paper
• T-DM1-resistant cells gain high invasive activity via EGFR and integrin cooperated pathways

  2018cites this paper